UK markets closed

Enveric Biosciences, Inc. (ENVB)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.9000-0.2050 (-6.60%)
As of 02:17PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close3.1050
Open2.8600
Bid2.8800 x 1100
Ask2.9500 x 4000
Day's range2.7600 - 2.9500
52-week range2.6100 - 71.0000
Volume62,176
Avg. volume78,587
Market cap6.027M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.6670
Earnings date14 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date23 Apr 2008
1y target est14.00
  • Business Wire

    Enveric Biosciences Announces Confidential Submission of Registration Statement for the Spin-off of its Cannabinoid Business to Shareholders

    CAMBRIDGE, Mass., November 28, 2022--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, today announced the confidential submission of a Form S-1 draft registration statement with the U.S. Securities and Exchange Commission (‘SEC’) for the spin-off its cannabinoid clinical development pipeline to a wholly-owned subsidiary, Akos

  • Business Wire

    Enveric Biosciences to Participate in A.G.P.’s Virtual Biotech Conference

    CAMBRIDGE, Mass., November 16, 2022--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, today announced that Avani Kanubaddi, President & COO of Enveric Biosciences, will participate in A.G.P.’s Virtual Biotech Conference to be held from November 30, 2022 – December 1, 2022.

  • Business Wire

    Enveric Biosciences to Participate in Wonderland: Miami on November 3-5, 2022

    CAMBRIDGE, Mass., November 01, 2022--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in Wonderland: Miami hosted by Microdose to be held at the Mana Wynwood Convention Center in Miami, FL on November 3-5, 2022.